Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.4 USD | +5.93% | +12.48% | -10.16% |
08/05 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
08/05 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.16% | 261.12Cr | |
+4.89% | 11TCr | |
+10.86% | 11TCr | |
-0.38% | 2.23TCr | |
-11.69% | 2.21TCr | |
-7.66% | 1.87TCr | |
-36.52% | 1.76TCr | |
-9.57% | 1.69TCr | |
+4.01% | 1.38TCr | |
+35.58% | 1.25TCr |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Wedbush Lowers Denali Therapeutics' Price Target to $31 From $37 Following Pipeline Updates, Keeps Outperform Rating